speb/financial-data huggingface dataset:
BMA.OL balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 19139000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Current Debt: 546312000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 565451000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Current Liabilities: 1105780000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Current Provisions: 2150000.00
BMA.OL cash_flow (annual, 2022-12-31) — Deferred Tax: 48937000.00
BMA.OL cash_flow (annual, 2022-12-31) — Depreciation: 77377000.00
BMA.OL cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 80935000.00
BMA.OL income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 82037000.00
BMA.OL income_statement (annual, 2022-12-31) — Depreciation Income Statement: 82037000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 0.00
BMA.OL income_statement (annual, 2022-12-31) — Diluted Average Shares: 69819000.00
BMA.OL income_statement (annual, 2022-12-31) — Diluted EPS: 6.16
BMA.OL income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 429774000.00
BMA.OL cash_flow (annual, 2022-12-31) — Dividends Received Cfi: 0.00
BMA.OL income_statement (annual, 2022-12-31) — EBIT: 569125000.00
BMA.OL income_statement (annual, 2022-12-31) — EBITDA: 651162000.00
BMA.OL cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -698000.00
BMA.OL cash_flow (annual, 2022-12-31) — End Cash Position: 37076000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Financial Assets: 194672000.00
BMA.OL cash_flow (annual, 2022-12-31) — Financing Cash Flow: 783688000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Finished Goods: 188025000.00
BMA.OL cash_flow (annual, 2022-12-31) — Free Cash Flow: 184465000.00
BMA.OL cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -251200000.00
BMA.OL cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -1602000.00
BMA.OL income_statement (annual, 2022-12-31) — General And Administrative Expense: 22464000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Goodwill: 6341000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 20609000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 329630000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Gross PPE: 1841714000.00
BMA.OL income_statement (annual, 2022-12-31) — Gross Profit: 1180935000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 135074000.00
BMA.OL income_statement (annual, 2022-12-31) — Interest Expense: 39768000.00
BMA.OL income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 39768000.00
BMA.OL income_statement (annual, 2022-12-31) — Interest Income: 732000.00
BMA.OL income_statement (annual, 2022-12-31) — Interest Income Non Operating: 732000.00
BMA.OL cash_flow (annual, 2022-12-31) — Interest Paid Cfo: -38299000.00
BMA.OL cash_flow (annual, 2022-12-31) — Interest Received Cfo: 5938000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Inventory: 385743000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Invested Capital: 2455950000.00
BMA.OL cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1131855000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Investment Properties: 175000000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Investmentsin Associatesat Cost: 1078046000.00
BMA.OL cash_flow (annual, 2022-12-31) — Issuance Of Debt: 867652000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Land And Improvements: 73929000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 65079000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Long Term Debt: 831926000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 897005000.00
BMA.OL cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 867652000.00
BMA.OL cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -87529000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 1078046000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 1254098000.00
BMA.OL income_statement (annual, 2022-12-31) — Minority Interests: 0.00
BMA.OL cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -1016333000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Net Debt: 1358771000.00
BMA.OL income_statement (annual, 2022-12-31) — Net Income: 429774000.00
BMA.OL income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 429774000.00
BMA.OL income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 429774000.00
BMA.OL income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 429774000.00
BMA.OL income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 429774000.00
BMA.OL cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 429774000.00
BMA.OL income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 429774000.00
BMA.OL cash_flow (annual, 2022-12-31) — Net Intangibles Purchase And Sale: -2484000.00
BMA.OL income_statement (annual, 2022-12-31) — Net Interest Income: -41415000.00
BMA.OL cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: -1016333000.00
BMA.OL cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 853508000.00
BMA.OL cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 780123000.00
BMA.OL income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -41415000.00
BMA.OL cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -1000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Net PPE: 853454000.00
BMA.OL cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -112657000.00
BMA.OL cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 73385000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 1057103000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 1162000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 179317000.00
BMA.OL income_statement (annual, 2022-12-31) — Normalized EBITDA: 558635000.00
BMA.OL income_statement (annual, 2022-12-31) — Normalized Income: 354653242.37
BMA.OL cash_flow (annual, 2022-12-31) — Operating Cash Flow: 314979000.00
BMA.OL income_statement (annual, 2022-12-31) — Operating Income: 141107000.00
BMA.OL income_statement (annual, 2022-12-31) — Operating Revenue: 2508195000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 69819290.00
BMA.OL cash_flow (annual, 2022-12-31) — Other Cash Adjustment Outside Changein Cash: 1000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Other Equity Interest: -6388000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 14268000.00
BMA.OL cash_flow (annual, 2022-12-31) — Other Non Cash Items: 32361000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 1000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: -2000.00
BMA.OL income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 357138000.00
BMA.OL income_statement (annual, 2022-12-31) — Other Operating Expenses: 304118000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Other Receivables: 6179000.00
BMA.OL income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
BMA.OL balance_sheet (annual, 2022-12-31) — Payables: 460323000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Prepaid Assets: 45694000.00
BMA.OL income_statement (annual, 2022-12-31) — Pretax Income: 529357000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Properties: 0.00
BMA.OL cash_flow (annual, 2022-12-31) — Purchase Of Business: -1016333000.00
BMA.OL cash_flow (annual, 2022-12-31) — Purchase Of Intangibles: -2484000.00
BMA.OL cash_flow (annual, 2022-12-31) — Purchase Of Investment: -1016333000.00
BMA.OL cash_flow (annual, 2022-12-31) — Purchase Of PPE: -128030000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Raw Materials: 160341000.00
BMA.OL income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 1327260000.00
BMA.OL income_statement (annual, 2022-12-31) — Reconciled Depreciation: 80935000.00
BMA.OL income_statement (annual, 2022-12-31) — Rent And Landing Fees: 50759000.00
BMA.OL income_statement (annual, 2022-12-31) — Rent Expense Supplemental: 50759000.00
BMA.OL cash_flow (annual, 2022-12-31) — Repayment Of Debt: -87529000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Restricted Cash: 17609000.00
BMA.OL income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 0.00
BMA.OL balance_sheet (annual, 2022-12-31) — Retained Earnings: 1031448000.00
BMA.OL cash_flow (annual, 2022-12-31) — Sale Of PPE: 15373000.00
BMA.OL income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 103689000.00
BMA.OL income_statement (annual, 2022-12-31) — Selling General And Administration: 126153000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Share Issued: 69833210.00
BMA.OL income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
BMA.OL balance_sheet (annual, 2022-12-31) — Stockholders Equity: 1077712000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Tangible Book Value: 1057103000.00
BMA.OL income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 17406242.37
BMA.OL income_statement (annual, 2022-12-31) — Tax Provision: 99583000.00
BMA.OL income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.19
BMA.OL cash_flow (annual, 2022-12-31) — Taxes Refund Paid: -41068000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Total Assets: 3259812000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Total Capitalization: 1909638000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Total Debt: 1462456000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 1077712000.00
BMA.OL income_statement (annual, 2022-12-31) — Total Expenses: 2367088000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 2182100000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 2323094000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1076320000.00
BMA.OL income_statement (annual, 2022-12-31) — Total Other Finance Cost: 2379000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Total Tax Payable: 106729000.00
BMA.OL income_statement (annual, 2022-12-31) — Total Unusual Items: 92527000.00
BMA.OL income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 92527000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 13920.00
BMA.OL balance_sheet (annual, 2022-12-31) — Treasury Stock: 4000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Work In Process: 37377000.00
BMA.OL balance_sheet (annual, 2022-12-31) — Working Capital: -169062000.00
BMA.OL income_statement (annual, 2023-12-31) — +Operating Expense: 1056951000.00
BMA.OL income_statement (annual, 2023-12-31) — +Total Revenue: 2230916000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Accounts Payable: 376035000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Accounts Receivable: 376375000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -1110539000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 34499000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -3008000.00
BMA.OL cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 4421000.00
BMA.OL income_statement (annual, 2023-12-31) — Basic Average Shares: 69819000.00
BMA.OL income_statement (annual, 2023-12-31) — Basic EPS: 0.87
BMA.OL cash_flow (annual, 2023-12-31) — Beginning Cash Position: 37076000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 500116000.00
BMA.OL cash_flow (annual, 2023-12-31) — Capital Expenditure: -56670000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 84541000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Capital Stock: 18157000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 47338000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 47338000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Cash Financial: 47338000.00
BMA.OL cash_flow (annual, 2023-12-31) — Change In Inventory: 40362000.00
BMA.OL cash_flow (annual, 2023-12-31) — Change In Payable: 17305000.00
BMA.OL cash_flow (annual, 2023-12-31) — Change In Receivables: 4253000.00
BMA.OL cash_flow (annual, 2023-12-31) — Change In Working Capital: 61920000.00
BMA.OL cash_flow (annual, 2023-12-31) — Changes In Cash: 25094000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Common Stock: 18157000.00
BMA.OL cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: 0.00
BMA.OL balance_sheet (annual, 2023-12-31) — Common Stock Equity: 1129079000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Construction In Progress: 23338000.00
BMA.OL income_statement (annual, 2023-12-31) — Cost Of Revenue: 1094604000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Current Assets: 846829000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 21709000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Current Debt: 568661000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 590370000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Current Liabilities: 1135105000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Current Provisions: 2450000.00
BMA.OL cash_flow (annual, 2023-12-31) — Deferred Tax: -29655000.00
BMA.OL cash_flow (annual, 2023-12-31) — Depreciation: 85794000.00
BMA.OL cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 90215000.00
BMA.OL income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 119264000.00
BMA.OL income_statement (annual, 2023-12-31) — Depreciation Income Statement: 119264000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 0.00
BMA.OL income_statement (annual, 2023-12-31) — Diluted Average Shares: 69819000.00
BMA.OL income_statement (annual, 2023-12-31) — Diluted EPS: 0.87
BMA.OL income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 60998000.00
BMA.OL cash_flow (annual, 2023-12-31) — Dividends Received Cfi: 11678000.00
BMA.OL income_statement (annual, 2023-12-31) — EBIT: 127454000.00
BMA.OL income_statement (annual, 2023-12-31) — EBITDA: 246718000.00
BMA.OL cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 1035000.00
BMA.OL cash_flow (annual, 2023-12-31) — End Cash Position: 63205000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Financial Assets: 77987000.00
BMA.OL cash_flow (annual, 2023-12-31) — Financing Cash Flow: -57976000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Finished Goods: 160234000.00
BMA.OL cash_flow (annual, 2023-12-31) — Free Cash Flow: 157049000.00
BMA.OL cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 212134000.00
BMA.OL cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -897000.00
BMA.OL income_statement (annual, 2023-12-31) — General And Administrative Expense: 25442000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Goodwill: 6625000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 20443000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 344323000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Gross PPE: 1929955000.00
BMA.OL income_statement (annual, 2023-12-31) — Gross Profit: 1136312000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Hedging Assets Current: 57624000.00
BMA.OL income_statement (annual, 2023-12-31) — Interest Expense: 96111000.00
BMA.OL income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 96111000.00
BMA.OL income_statement (annual, 2023-12-31) — Interest Income: 859000.00
BMA.OL income_statement (annual, 2023-12-31) — Interest Income Non Operating: 859000.00
BMA.OL cash_flow (annual, 2023-12-31) — Interest Paid Cfo: -104763000.00
BMA.OL cash_flow (annual, 2023-12-31) — Interest Received Cfo: 22862000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Inventory: 349625000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Invested Capital: 2483413000.00
BMA.OL cash_flow (annual, 2023-12-31) — Investing Cash Flow: -130649000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Investment Properties: 157000000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Investmentsin Associatesat Cost: 1317202000.00
BMA.OL cash_flow (annual, 2023-12-31) — Issuance Of Debt: 5331000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Land And Improvements: 74518000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 62832000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Long Term Debt: 785673000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 848505000.00
BMA.OL cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 5331000.00
BMA.OL cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -132931000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 1317202000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1331982000.00
BMA.OL income_statement (annual, 2023-12-31) — Minority Interests: 0.00
BMA.OL cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: -87155000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Net Debt: 1306996000.00
BMA.OL income_statement (annual, 2023-12-31) — Net Income: 60998000.00
BMA.OL income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 60998000.00
BMA.OL income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 60998000.00
BMA.OL income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 60998000.00
BMA.OL cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 60998000.00
BMA.OL income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 60998000.00
BMA.OL cash_flow (annual, 2023-12-31) — Net Intangibles Purchase And Sale: -3755000.00
BMA.OL income_statement (annual, 2023-12-31) — Net Interest Income: -95995000.00
BMA.OL cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -57976000.00
BMA.OL cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -127600000.00
BMA.OL income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -95995000.00
BMA.OL cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 1000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Net PPE: 819416000.00
BMA.OL cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -51943000.00
BMA.OL cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 69624000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 1108636000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 1441000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 127871000.00
BMA.OL income_statement (annual, 2023-12-31) — Normalized EBITDA: 234794000.00
BMA.OL income_statement (annual, 2023-12-31) — Normalized Income: 51697280.00
BMA.OL cash_flow (annual, 2023-12-31) — Operating Cash Flow: 213719000.00
BMA.OL income_statement (annual, 2023-12-31) — Operating Income: 79361000.00
BMA.OL income_statement (annual, 2023-12-31) — Operating Revenue: 2230916000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 69819290.00
BMA.OL balance_sheet (annual, 2023-12-31) — Other Equity Interest: -16019000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 13818000.00
BMA.OL cash_flow (annual, 2023-12-31) — Other Non Cash Items: 72768000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: -1000.00
BMA.OL income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -106344000.00
BMA.OL income_statement (annual, 2023-12-31) — Other Operating Expenses: 285758000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Other Properties: 1000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Other Receivables: 5307000.00
BMA.OL income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 0.00
BMA.OL balance_sheet (annual, 2023-12-31) — Payables: 452126000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Prepaid Assets: 29753000.00
BMA.OL income_statement (annual, 2023-12-31) — Pretax Income: 31343000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Properties: 0.00
BMA.OL cash_flow (annual, 2023-12-31) — Purchase Of Business: -87155000.00
BMA.OL cash_flow (annual, 2023-12-31) — Purchase Of Intangibles: -3755000.00
BMA.OL cash_flow (annual, 2023-12-31) — Purchase Of PPE: -52915000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Raw Materials: 164125000.00
BMA.OL income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 1094604000.00
BMA.OL income_statement (annual, 2023-12-31) — Reconciled Depreciation: 90215000.00
BMA.OL income_statement (annual, 2023-12-31) — Rent And Landing Fees: 44951000.00
BMA.OL income_statement (annual, 2023-12-31) — Rent Expense Supplemental: 44951000.00
BMA.OL cash_flow (annual, 2023-12-31) — Repayment Of Debt: -132931000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Restricted Cash: 15867000.00
BMA.OL income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: -9133000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Retained Earnings: 1092446000.00
BMA.OL cash_flow (annual, 2023-12-31) — Sale Of PPE: 972000.00
BMA.OL income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 102005000.00
BMA.OL income_statement (annual, 2023-12-31) — Selling General And Administration: 127447000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Share Issued: 69833210.00
BMA.OL income_statement (annual, 2023-12-31) — Special Income Charges: 9133000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Stockholders Equity: 1129079000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Tangible Book Value: 1108636000.00
BMA.OL income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 2623280.00
BMA.OL income_statement (annual, 2023-12-31) — Tax Provision: -29655000.00
BMA.OL income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.22
BMA.OL cash_flow (annual, 2023-12-31) — Taxes Refund Paid: -40513000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Total Assets: 3240559000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Total Capitalization: 1914752000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Total Debt: 1438875000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 1129079000.00
BMA.OL income_statement (annual, 2023-12-31) — Total Expenses: 2151555000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 2111480000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 2393730000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 976375000.00
BMA.OL income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -35900000.00
BMA.OL income_statement (annual, 2023-12-31) — Total Other Finance Cost: 743000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Total Tax Payable: 76091000.00
BMA.OL income_statement (annual, 2023-12-31) — Total Unusual Items: 11924000.00
BMA.OL income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: 11924000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 13920.00
BMA.OL balance_sheet (annual, 2023-12-31) — Treasury Stock: 4000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Work In Process: 25266000.00
BMA.OL balance_sheet (annual, 2023-12-31) — Working Capital: -288276000.00
BMA.OL balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 100000.00
BMA.OL balance_sheet (quarterly, 2024-09-30) — Other Non Current Liabilities: -100000.00
BMA.OL income_statement (quarterly, 2024-09-30) — Restructuring And Mergern Acquisition: 0.00
BMA.OL income_statement (quarterly, 2024-09-30) — Special Income Charges: 0.00
BMA.OL income_statement (annual, 2024-12-31) — +Operating Expense: 1030470000.00
BMA.OL income_statement (annual, 2024-12-31) — +Total Revenue: 2173468000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Accounts Payable: 295097000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Accounts Receivable: 358776000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -1196129000.00
BMA.OL balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -1196129000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 34499000.00
BMA.OL income_statement (annual, 2024-12-31) — Amortization: 4301000.00
BMA.OL cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 4301000.00
BMA.OL income_statement (annual, 2024-12-31) — Basic Average Shares: 69819000.00
BMA.OL income_statement (annual, 2024-12-31) — Basic EPS: -3.70
BMA.OL cash_flow (annual, 2024-12-31) — Beginning Cash Position: 63205000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Buildings And Improvements: 500433000.00
BMA.OL balance_sheet (quarterly, 2024-12-31) — Buildings And Improvements: 500433000.00
BMA.OL cash_flow (annual, 2024-12-31) — Capital Expenditure: -37148000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 62779000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Capital Stock: 18157000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 35395000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 35395000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Cash Financial: 35395000.00
BMA.OL balance_sheet (quarterly, 2024-12-31) — Cash Financial: 35395000.00
BMA.OL cash_flow (annual, 2024-12-31) — Change In Inventory: -11800000.00
BMA.OL cash_flow (annual, 2024-12-31) — Change In Payable: -50386000.00
BMA.OL cash_flow (annual, 2024-12-31) — Change In Receivables: 18467000.00
BMA.OL cash_flow (annual, 2024-12-31) — Change In Working Capital: -43719000.00
BMA.OL cash_flow (annual, 2024-12-31) — Changes In Cash: -12071000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Common Stock: 18157000.00
BMA.OL cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: 0.00
BMA.OL balance_sheet (annual, 2024-12-31) — Common Stock Equity: 912509000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Construction In Progress: 29519000.00
BMA.OL balance_sheet (quarterly, 2024-12-31) — Construction In Progress: 29519000.00
BMA.OL income_statement (annual, 2024-12-31) — Cost Of Revenue: 1060826000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Current Assets: 779716000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 21339000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Current Debt: 537760000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 559099000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Current Liabilities: 1036671000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Current Provisions: 2450000.00
BMA.OL balance_sheet (quarterly, 2024-12-31) — Current Provisions: 2450000.00
BMA.OL cash_flow (annual, 2024-12-31) — Deferred Tax: -14262000.00
BMA.OL cash_flow (annual, 2024-12-31) — Depreciation: 83519000.00
BMA.OL cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 87820000.00
BMA.OL income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 87820000.00
BMA.OL income_statement (annual, 2024-12-31) — Depreciation Income Statement: 83519000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Derivative Product Liabilities: 0.00
BMA.OL balance_sheet (quarterly, 2024-12-31) — Derivative Product Liabilities: 0.00
BMA.OL income_statement (annual, 2024-12-31) — Diluted Average Shares: 69819000.00
BMA.OL income_statement (annual, 2024-12-31) — Diluted EPS: -3.70
BMA.OL income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -258579000.00
BMA.OL cash_flow (annual, 2024-12-31) — Dividends Received Cfi: 0.00
BMA.OL income_statement (annual, 2024-12-31) — EBIT: -173255000.00
BMA.OL income_statement (annual, 2024-12-31) — EBITDA: -85435000.00
BMA.OL cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 282000.00
BMA.OL cash_flow (annual, 2024-12-31) — End Cash Position: 51416000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Financial Assets: 24937000.00
BMA.OL cash_flow (annual, 2024-12-31) — Financing Cash Flow: -31756000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Finished Goods: 180340000.00
BMA.OL balance_sheet (quarterly, 2024-12-31) — Finished Goods: 180340000.00
BMA.OL cash_flow (annual, 2024-12-31) — Free Cash Flow: 19846000.00
BMA.OL cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 103504000.00
BMA.OL cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: -100000.00
BMA.OL income_statement (annual, 2024-12-31) — General And Administrative Expense: 26750000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Goodwill: 6693000.00
BMA.OL balance_sheet (quarterly, 2024-12-31) — Goodwill: 6693000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 17969000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Gross PPE: 1969320000.00
BMA.OL balance_sheet (quarterly, 2024-12-31) — Gross PPE: 1969320000.00
BMA.OL income_statement (annual, 2024-12-31) — Gross Profit: 1112642000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Hedging Assets Current: 7171000.00
BMA.OL income_statement (annual, 2024-12-31) — Interest Expense: 99586000.00
BMA.OL income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 99586000.00
BMA.OL income_statement (annual, 2024-12-31) — Interest Income: 719000.00
BMA.OL income_statement (annual, 2024-12-31) — Interest Income Non Operating: 719000.00
BMA.OL cash_flow (annual, 2024-12-31) — Interest Paid Cfo: -86467000.00
BMA.OL cash_flow (annual, 2024-12-31) — Interest Received Cfo: 719000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Inventory: 362353000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Invested Capital: 2266965000.00
BMA.OL cash_flow (annual, 2024-12-31) — Investing Cash Flow: -37309000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Investment Properties: 157000000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Investmentsin Associatesat Cost: 1157517000.00
BMA.OL cash_flow (annual, 2024-12-31) — Issuance Of Debt: 68492000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Land And Improvements: 74660000.00
BMA.OL balance_sheet (quarterly, 2024-12-31) — Land And Improvements: 74660000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 41440000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Long Term Debt: 816696000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 858136000.00
BMA.OL cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 68492000.00
BMA.OL cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -234006000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Long Term Equity Investment: 1157517000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 1364708000.00
BMA.OL balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 1364708000.00
BMA.OL income_statement (annual, 2024-12-31) — Minority Interests: 0.00
BMA.OL cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
BMA.OL balance_sheet (annual, 2024-12-31) — Net Debt: 1319061000.00
BMA.OL income_statement (annual, 2024-12-31) — Net Income: -258579000.00
BMA.OL income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -258579000.00
BMA.OL income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -258579000.00
BMA.OL income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -258579000.00
BMA.OL income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -258579000.00
BMA.OL cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -258579000.00
BMA.OL income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -258579000.00
BMA.OL cash_flow (annual, 2024-12-31) — Net Intangibles Purchase And Sale: -1712000.00
BMA.OL income_statement (annual, 2024-12-31) — Net Interest Income: -99202000.00
BMA.OL cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: -31757000.00
BMA.OL cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: -165514000.00
BMA.OL income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -99202000.00
BMA.OL cash_flow (annual, 2024-12-31) — Net Other Financing Charges: 1000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Net PPE: 773194000.00
BMA.OL cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -35291000.00
BMA.OL cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 133757000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 894540000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 1263000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 104483000.00
BMA.OL income_statement (annual, 2024-12-31) — Normalized EBITDA: -91205000.00
BMA.OL income_statement (annual, 2024-12-31) — Normalized Income: -264047389.39
BMA.OL cash_flow (annual, 2024-12-31) — Operating Cash Flow: 56994000.00
BMA.OL income_statement (annual, 2024-12-31) — Operating Income: 82172000.00
BMA.OL income_statement (annual, 2024-12-31) — Operating Revenue: 2173468000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 69819290.00
BMA.OL balance_sheet (annual, 2024-12-31) — Other Equity Interest: 26013000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 11276000.00
BMA.OL balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 11276000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Other Inventories: 1000.00
BMA.OL balance_sheet (quarterly, 2024-12-31) — Other Inventories: 1000.00
BMA.OL cash_flow (annual, 2024-12-31) — Other Non Cash Items: 92311000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 2000.00
BMA.OL balance_sheet (quarterly, 2024-12-31) — Other Non Current Liabilities: 2000.00
BMA.OL income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -59825000.00
BMA.OL income_statement (annual, 2024-12-31) — Other Operating Expenses: 292587000.00
BMA.OL income_statement (annual, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
BMA.OL balance_sheet (annual, 2024-12-31) — Payables: 362083000.00
BMA.OL income_statement (annual, 2024-12-31) — Pretax Income: -272841000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Properties: 0.00
BMA.OL balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
BMA.OL cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
BMA.OL cash_flow (annual, 2024-12-31) — Purchase Of Intangibles: -1712000.00
BMA.OL cash_flow (annual, 2024-12-31) — Purchase Of PPE: -35436000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Raw Materials: 155752000.00
BMA.OL balance_sheet (quarterly, 2024-12-31) — Raw Materials: 155752000.00
BMA.OL income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 1060826000.00
BMA.OL income_statement (annual, 2024-12-31) — Reconciled Depreciation: 87820000.00
BMA.OL income_statement (annual, 2024-12-31) — Rent And Landing Fees: 38261000.00
BMA.OL income_statement (annual, 2024-12-31) — Rent Expense Supplemental: 38261000.00
BMA.OL cash_flow (annual, 2024-12-31) — Repayment Of Debt: -234006000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Restricted Cash: 16021000.00
BMA.OL balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 16021000.00
BMA.OL income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
BMA.OL income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
BMA.OL balance_sheet (annual, 2024-12-31) — Retained Earnings: 833844000.00
BMA.OL cash_flow (annual, 2024-12-31) — Sale Of PPE: 145000.00
BMA.OL income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 97477000.00
BMA.OL income_statement (annual, 2024-12-31) — Selling General And Administration: 124227000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Share Issued: 69833210.00
BMA.OL income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
BMA.OL income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
BMA.OL balance_sheet (annual, 2024-12-31) — Stockholders Equity: 912509000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Tangible Book Value: 894540000.00
BMA.OL income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 301610.61
BMA.OL income_statement (annual, 2024-12-31) — Tax Provision: -14262000.00
BMA.OL income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.05
BMA.OL cash_flow (annual, 2024-12-31) — Taxes Refund Paid: -25990000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Total Assets: 2911801000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Total Capitalization: 1729205000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Total Debt: 1417235000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 912509000.00
BMA.OL income_statement (annual, 2024-12-31) — Total Expenses: 2091296000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 1999292000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 2132085000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 962621000.00
BMA.OL income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 22349000.00
BMA.OL income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: -14400000.00
BMA.OL income_statement (annual, 2024-12-31) — Total Other Finance Cost: 335000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Total Tax Payable: 66986000.00
BMA.OL income_statement (annual, 2024-12-31) — Total Unusual Items: 5770000.00
BMA.OL income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 5770000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 13920.00
BMA.OL balance_sheet (quarterly, 2024-12-31) — Treasury Shares Number: 13920.00
BMA.OL balance_sheet (annual, 2024-12-31) — Treasury Stock: 4000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Work In Process: 26260000.00
BMA.OL balance_sheet (quarterly, 2024-12-31) — Work In Process: 26260000.00
BMA.OL balance_sheet (annual, 2024-12-31) — Working Capital: -256955000.00
BMA.OL income_statement (quarterly, 2025-03-31) — +Operating Expense: 248700000.00
BMA.OL income_statement (quarterly, 2025-03-31) — +Total Revenue: 636000000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 491800000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 431700000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 34600000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Basic Average Shares: 69705882.00
BMA.OL income_statement (quarterly, 2025-03-31) — Basic EPS: 1.36
BMA.OL cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 51400000.00
BMA.OL cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -20600000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 309900000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Capital Stock: 18200000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 35300000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 35300000.00
BMA.OL cash_flow (quarterly, 2025-03-31) — Changes In Cash: -16400000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Common Stock: 18200000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 980500000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 342100000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Current Assets: 845800000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 21200000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Current Debt: 567200000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 588400000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 1088500000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 22000000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 22000000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Derivative Product Liabilities: 900000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 69705882.00
BMA.OL income_statement (quarterly, 2025-03-31) — Diluted EPS: 1.36
BMA.OL income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 94800000.00
BMA.OL cash_flow (quarterly, 2025-03-31) — Dividends Received Cfi: 0.00
BMA.OL income_statement (quarterly, 2025-03-31) — EBIT: 123100000.00
BMA.OL income_statement (quarterly, 2025-03-31) — EBITDA: 145100000.00
BMA.OL cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 200000.00
BMA.OL cash_flow (quarterly, 2025-03-31) — End Cash Position: 35300000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Financial Assets: 10500000.00
BMA.OL cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 13500000.00
BMA.OL cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -29800000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 17300000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Gross Profit: 293900000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 7100000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Interest Expense: 24600000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 24600000.00
BMA.OL cash_flow (quarterly, 2025-03-31) — Interest Paid Cfo: -18300000.00
BMA.OL cash_flow (quarterly, 2025-03-31) — Interest Received Cfo: 100000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Inventory: 371700000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Invested Capital: 2125900000.00
BMA.OL cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -20700000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Investment Properties: 157000000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Investmentsin Associatesat Cost: 1211300000.00
BMA.OL cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 20400000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 288700000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 578200000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 866900000.00
BMA.OL cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 20400000.00
BMA.OL cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -13800000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 1211300000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Minority Interests: 0.00
BMA.OL cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 0.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Net Debt: 1110100000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Net Income: 94800000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 94800000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 94800000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 94800000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 94800000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 94800000.00
BMA.OL cash_flow (quarterly, 2025-03-31) — Net Intangibles Purchase And Sale: -300000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Net Interest Income: -25300000.00
BMA.OL cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 13500000.00
BMA.OL cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 6600000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -25300000.00
BMA.OL cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -100000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Net PPE: 794700000.00
BMA.OL cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -20300000.00
BMA.OL cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 6900000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 963200000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 1100000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 101600000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 136400000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Normalized Income: 86426802.03
BMA.OL cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -9200000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Operating Income: 45200000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Operating Revenue: 636000000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 69819290.00
BMA.OL cash_flow (quarterly, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: 100000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: -600000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 100000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: -300000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -12400000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 78900000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Payables: 500100000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Pretax Income: 98500000.00
BMA.OL cash_flow (quarterly, 2025-03-31) — Purchase Of Business: 0.00
BMA.OL cash_flow (quarterly, 2025-03-31) — Purchase Of Intangibles: -300000.00
BMA.OL cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -20300000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 342100000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 22000000.00
BMA.OL cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -13800000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 928300000.00
BMA.OL cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 0.00
BMA.OL income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 21000000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Selling General And Administration: 21000000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Share Issued: 69833210.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 980500000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 963200000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 326802.03
BMA.OL income_statement (quarterly, 2025-03-31) — Tax Provision: 3700000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.04
BMA.OL cash_flow (quarterly, 2025-03-31) — Taxes Refund Paid: -5900000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Total Assets: 3038100000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1558700000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Total Debt: 1455300000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 980500000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Total Expenses: 590800000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2057600000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 2192300000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 969100000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 40900000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Total Other Finance Cost: 700000.00
BMA.OL balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 8300000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Total Unusual Items: 8700000.00
BMA.OL income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 8700000.00